NAD+ 500mg/vial – US Stock

$51.73

NAD+ 500mg/vial is a lyophilized product containing nicotinamide adenine dinucleotide (NAD+) as the active compound. Supplied by Hilma Biocare in a 1-vial format, it is listed as an injection/powder formulation and available as US Stock.

Product Protected
This product is protected by Hilma Biocare™ Verification
Categories: , ,
Description

NAD+ 500mg/vial – US Stock

NAD+ 500mg/vial from Hilma Biocare contains nicotinamide adenine dinucleotide (NAD+), a coenzyme naturally present in living cells. The product is supplied as an injection/powder formulation with 500 mg of NAD+ per vial and a 1-vial pack.

Product Overview

Nicotinamide adenine dinucleotide exists in oxidized and reduced forms, NAD+ and NADH. According to the supplied product information, NAD+ participates in cellular redox reactions by accepting and donating electrons and is involved in metabolic processes.

The supplied specifications identify NAD+ as the active compound and list the product under the peptide hormone subgroup, with an active half-life of 7–30 minutes.

Key Product Characteristics

  • Active Ingredient: NAD+
  • Full Name: Nicotinamide adenine dinucleotide
  • Strength: 500 mg/vial
  • Form: Injection/powder
  • Product Type: Peptide hormone, according to supplied specifications
  • Pack Size: 1 vial
  • Active Half-Life: 7–30 minutes
  • Manufacturer/Brand: Hilma Biocare
  • US Availability: US Stock
  • Water Retention: Listed as No
  • Aromatization: Listed as No

Product Specifications

Specification Details
Brand Hilma Biocare
Active Ingredient NAD+
Full Name Nicotinamide adenine dinucleotide
Strength 500 mg/vial
Form Injection/powder
Product Type Peptide hormone, according to supplied specifications
Pack Size 1 vial
Active Half-Life 7–30 minutes
Water Retention No, according to supplied specifications
Aromatization No, according to supplied specifications

Product Characteristics

NAD+ is described in the supplied information as a coenzyme involved in cellular metabolism and redox reactions. The source identifies NAD+ as participating in processes associated with energy production, DNA repair, immune function, and metabolic regulation.

The product description also discusses NAD+ in the context of mitochondrial energy production, cellular metabolism, and age-related changes in NAD+ levels. These descriptions reflect the supplied source material and should not be interpreted as established therapeutic claims, guaranteed outcomes, or personalized medical advice.

About Hilma Biocare USA

NAD+ 500mg/vial is part of the Hilma Biocare product range. It is supplied as a 500 mg lyophilized injection/powder formulation in a 1-vial pack and is listed as US Stock.

Important Information

NAD+ is a biologically relevant compound, and the supplied source includes information concerning administration, dosage, contraindications, drug interactions, and potential side effects. Actionable dosing schedules and self-administration instructions are not reproduced here.

The supplied information notes that individuals with certain medical conditions or those taking medications should consult a qualified healthcare professional before considering NAD+. Anyone considering a medically relevant product should discuss suitability, potential interactions, and risks with an appropriately qualified healthcare professional.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “NAD+ 500mg/vial – US Stock”

Your email address will not be published. Required fields are marked *